PCVX today
$65.82-$2.80 (-4.08%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourBearish
15 minBearish
5 minStrong Bearish
Daily trend turns down below $55.09
Key levels
Resistance$76.61
Resistance$69.38
Support$63.94
Support$59.58
About Vaxcyte
Vaxcyte is a clinical-stage vaccine company that makes vaccines against bacterial diseases using a synthetic, cell-free method of protein production. Its lead programs are pneumococcal conjugate vaccine candidates for adults and children, along with an earlier-stage candidate against Group A Streptococcus and a preclinical program targeting Shigella. The company operates in the United States and has no approved products.
Based on the company's 10-K filed Feb 24, 2026.
Nasdaq · Healthcare
Vaxcyte, Inc. (PCVX)
What Is the Price Target for PCVX?
SEPT Low Target
$120.00
SEPT Mid Target
$123.50
SEPT High Target
$130.00
Analyst Consensus
$123.50
Is PCVX a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PCVX.
Start Free Trial →Is PCVX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$102.79
12
Moat Score
NONE
1/9
Piotroski Score
15.5
Altman Z-Score
What Is Smart Money Doing with PCVX?
Insider Signal
SELLING
0 buys / 9 sells (90d)
Congress Signal
BUYING
4 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Cowan Elvia | officer | Buy | 3,000 | $78K | Nov 2, 2026 |
| Cowan Elvia | officer | Sale | 2,414 | $147K | Nov 2, 2026 |
| Cowan Elvia | officer | Sale | 586 | $36K | Nov 2, 2026 |
| Wassil Jim | officer | Buy | 2,250 | $12K | Nov 2, 2026 |
| Wassil Jim | officer | Sale | 1,907 | $116K | Nov 2, 2026 |
| Wassil Jim | officer | Sale | 343 | $21K | Nov 2, 2026 |
| Cowan Elvia | officer | Buy | 19,000 | $492K | Oct 5, 2026 |
| Cowan Elvia | officer | Sale | 19,000 | $1.6M | Oct 5, 2026 |
| Wassil Jim | officer | Buy | 18,000 | $96K | Oct 5, 2026 |
| Wassil Jim | officer | Sale | 18,000 | $1.6M | Oct 5, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PCVX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-48.16%
FCF Growth YoY
-40.9%
Revenue Trend
UNKNOWN
Dark Pool Trades for PCVX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PCVX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:40:40 | $65.61 | 16,821 | $$1.1M | SELL |
| 17:23:36 | $65.53 | 10,000 | $$655K | BUY |
| 17:23:30 | $65.50 | 10,000 | $$655K | SELL |
| 17:07:57 | $65.58 | 16,100 | $$1.1M | SELL |
| 16:22:56 | $65.60 | 1,090 | $$72K | SELL |
5 dark pool trades shown · $$3.5M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Vaxcyte, Inc. (PCVX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PCVX — frequently asked questions
What is PCVX stock price today?
Vaxcyte, Inc. (PCVX) is at $65.82, down 4.08% (-$2.80) at the Nov 12, 2026 close.
Why is PCVX stock moving today?
Latest PCVX news — Nov 4, 2026: Vaxcyte Posts Q3 2026 Results
What is the PCVX price target?
The average analyst price target for PCVX is $123.50, ranging from $120 to $130, based on 4 analysts.
What do analysts rate PCVX?
Analyst ratings for PCVX: 0 Buy, 6 Hold, 0 Sell — consensus Hold.
Did PCVX beat earnings?
PCVX last reported on Nov 4, 2026: EPS -$1.99 vs -$2.12 expected — a beat of 6.1%.
Does PCVX pay a dividend?
PCVX does not currently pay a dividend.
What are PCVX support and resistance levels?
Support: $63.94, $59.58, $55.09. Resistance: $69.38, $76.61, $84.10.
What are insiders doing with PCVX?
Insider activity: SELLING, 0 buys and 9 sells in the last 90 days.
What is the latest news on PCVX?
Nov 4, 2026: Vaxcyte Posts Q3 2026 Results